🔎 Trials Near Me

Beranda › Kanker Urogenital › Florida

Uji klinis Kanker Urogenital di Florida

6 studi untuk Kanker Urogenital mencari peserta di lokasi di Florida.

Kota di Florida

Teks studi resmi (Bahasa Inggris)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Holy Cross Hospital, Fort Lauderdale
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • University of Florida, Gainesville
  • Mount Sinai Medical Center of Florida, Inc., Miami
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05874921

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Florida Cancer Specialists, Sarasota
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT06800313

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • AdventHealth Celebration, Celebration
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Sylvester Comprehensive Cancer Center, Miami
  • Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT07103018

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

  • Biogenix Molecular LLC, Miami
  • NovaCure Health, Miami
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 14 Mei 2026 · NCT05413850

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.